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A 26-year-old male presented with a history of bilateral 
eyelid skin colour and consistency changes, with progres-
sive eye opening difficulty. At age 9, the patient experienced 
the first symptoms — bilateral eyelid swelling and erythema 
— with slow and progressive skin modifications over the 
years. Physical examination revealed bilateral ptosis, cuta-
neous laxity and atrophy with prominent epicanthic folds 
(Figs. 1 and 2).
A skin biopsy was performed, showing unspecific 
findings and a decrease in elastic fibers, thus supporting 
the clinical diagnosis of blepharochalasis. The patient was 
then referred to ophthalmology to undergo blepharoplasty.
Blepharochalasis is a rare disorder characterized by 
recurrent painless eyelid swelling followed by skin atrophy 
and laxity,1 and its etiology remains unknown, although 
an immune pathogenesis was suggested.2 The defini-
tive treatment is blepharoplasty in the quiescent stage of 
the disease.3,4
Figure 1 – Bilateral eyelid cutaneous laxity and atrophy and pseu-
doepicanthal fold. The patient is looking forward.
Figure 2 – Prominent right epicanthic fold. Note the junction of the 
upper eyelid under lower eyelid without a clear delimitation of the 
lateral canthus of the eye.
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